Elastin microfibril interface–located protein 1, transforming growth factor beta, and implications on cardiovascular complications

Journal of the American Society of Hypertension

Volumn 11, Issue 7, 2017, Pages 437-448

  Randell, Amy ^a   Daneshtalab, Noriko ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Disease interaction; genetic predisposition; hypertension; vascular integrity

Indexed keywords

ELASTIN MICROFIBRIL INTERFACE LOCATED PROTEIN 1; GLYCOPROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; ELASTIN MICROFIBRIL INTERFACE LOCATED PROTEIN; LATENCY-ASSOCIATED PROPEPTIDE, TGF-BETA; MEMBRANE PROTEIN; PEPTIDE; PROTEIN PRECURSOR; TGFB1 PROTEIN, HUMAN;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DRUG MECHANISM; GENETIC PREDISPOSITION; GENETIC VARIATION; HOMEOSTASIS; HUMAN; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; BLOOD PRESSURE; BLOOD VESSEL; CHEMISTRY; EXTRACELLULAR MATRIX; GENETICS; HEART DISEASE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOOTH MUSCLE CELL;

BLOOD PRESSURE; BLOOD VESSELS; EXTRACELLULAR MATRIX; HEART DISEASES; HUMANS; HYPERTENSION; MEMBRANE GLYCOPROTEINS; MYOCYTES, SMOOTH MUSCLE; PEPTIDES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN PRECURSORS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 85019860731     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2017.04.010     Document Type: Review

References (86)

1. Bou-Gharios, G., Ponticos, M., Rajkumar, V., Abraham, D., Extra-cellular matrix in vascular networks. Cell Prolif 37:3 (2004), 207–220.
2. Di Wang, H., Ratsep, M.T., Chapman, A., Boyd, R., Adventitial fibroblasts in vascular structure and function: the role of oxidative stress and beyond. Canadian J Physiol Pharmacol 88:3 (2010), 177–186.
3. Danussi, C., Del Bel Belluz, L., Pivetta, E., Modica, T.M., Muro, A., Wassermann, B., et al. EMILIN1/alpha9beta1 integrin interaction is crucial in lymphatic valve formation and maintenance. Mol Cell Biol 33:22 (2013), 4381–4394.
4. Danussi, C., Petrucco, A., Wassermann, B., Pivetta, E., Modica, T.M., Del Bel Belluz, L., et al. EMILIN1-alpha4/alpha9 integrin interaction inhibits dermal fibroblast and keratinocyte proliferation. J Cell Biol 195:1 (2011), 131–145.
5. Danussi, C., Spessotto, P., Petrucco, A., Wassermann, B., Sabatelli, P., Montesi, M., et al. Emilin1 deficiency causes structural and functional defects of lymphatic vasculature. Mol Cell Biol 28:12 (2008), 4026–4039.
6. August, P., Suthanthiran, M., Transforming growth factor beta signaling, vascular remodeling, and hypertension. N Engl J Med 354:25 (2006), 2721–2723.
7. Bijl, M., Endothelial activation, endothelial dysfunction and premature atherosclerosis in systemic autoimmune diseases. Neth J Med 61:9 (2003), 273–277.
8. Braghetta, P., Ferrari, A., De Gemmis, P., Zanetti, M., Volpin, D., Bonaldo, P., et al. Overlapping, complementary and site-specific expression pattern of genes of the EMILIN/Multimerin family. Matrix Biol 22:7 (2004), 549–556.
9. Garcia de Viedma, D., Giraldo, R., Rivas, G., Fernandez-Tresguerres, E., Diaz-Orejas, R., A leucine zipper motif determines different functions in a DNA replication protein. EMBO J 15:4 (1996), 925–934.
10. Kay, B.K., Williamson, M.P., Sudol, M., The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains. FASEB J 14:2 (2000), 231–241.
11. Williamson, M.P., The structure and function of proline-rich regions in proteins. Biochem J 297:Pt 2 (1994), 249–260.
12. Bressan, G.M., Daga-Gordini, D., Colombatti, A., Castellani, I., Marigo, V., Volpin, D., EMILIN, a component of elastic fibers preferentially located at the elastin-microfibrils interface. J Cell Biol 121:1 (1993), 201–212.
13. Schiavinato, A., Becker, A.K., Zanetti, M., Corallo, D., Milanetto, M., Bizzotto, D., et al. EMILIN-3, peculiar member of elastin microfibril interface-located protein (EMILIN) family, has distinct expression pattern, forms oligomeric assemblies, and serves as transforming growth factor beta (TGF-beta) antagonist. J Biol Chem 287:14 (2012), 11498–11515.
14. Spessotto, P., Cervi, M., Mucignat, M.T., Mungiguerra, G., Sartoretto, I., Doliana, R., et al. Beta 1 integrin-dependent cell adhesion to EMILIN-1 is mediated by the gC1q domain. J Biol Chem 278:8 (2003), 6160–6167.
15. Pivetta, E., Wassermann, B., Del Bel Belluz, L., Danussi, C., Modica, T.M., Maiorani, O., et al. Local inhibition of elastase reduces EMILIN1 cleavage reactivating lymphatic vessel function in a mouse lymphoedema model. Clin Sci (Lond) 130:14 (2016), 1221–1236.
16. Adam, F., Zheng, S., Joshi, N., Kelton, D.S., Sandhu, A., Suehiro, Y., et al. Analyses of cellular multimerin 1 receptors: in vitro evidence of binding mediated by alphaIIbbeta3 and alphavbeta3. Thromb Haemost 94:5 (2005), 1004–1011.
17. Jeimy, S.B., Tasneem, S., Cramer, E.M., Hayward, C.P., Multimerin 1. Platelets 19:2 (2008), 83–95.
18. Colombatti, A., Spessotto, P., Doliana, R., Mongiat, M., Bressan, G.M., Esposito, G., The EMILIN/multimerin family. Front Immunol, 2, 2011, 93.
19. Huang, M., Sannaningaiah, D., Zhao, N., Gong, Y., Grondolsky, J., Hoover-Plow, J., EMILIN2 regulates platelet activation, thrombus formation, and clot retraction. PLoS One, 10(2), 2015, e0115284.
20. Sa, Q., Hart, E., Nadeau, J.H., Hoover-Plow, J.L., Mouse chromosome 17 candidate modifier genes for thrombosis. Mamm Genome 21:7–8 (2010), 337–349.
21. Sa, Q., Hoover-Plow, J.L., EMILIN2 (elastin microfibril interface located protein), potential modifier of thrombosis. Thromb J, 9, 2011, 9.
22. Bot, S., Andreuzzi, E., Capuano, A., Schiavinato, A., Colombatti, A., Doliana, R., Multiple-interactions among EMILIN1 and EMILIN2 N- and C-terminal domains. Matrix Biol 41 (2015), 44–55.
23. Colombatti, A., Bressan, G.M., Castellani, I., Volpin, D., Glycoprotein 115, a glycoprotein isolated from chick blood vessels, is widely distributed in connective tissue. J Cell Biol 100:1 (1985), 18–26.
24. Keeley, F.W., Murray, R.K., The Extracellular Matrix. 29 ed., 2012, McGraw-Hill, New York, NY.
25. Lavoie, P., Robitaille, G., Agharazii, M., Ledbetter, S., Lebel, M., Lariviere, R., Neutralization of transforming growth factor-beta attenuates hypertension and prevents renal injury in uremic rats. J Hypertens 23:10 (2005), 1895–1903.
26. Tomiyama, Y., Yoshinaga, K., Fujii, S., Ochi, N., Inoue, M., Nishida, M., et al. Accurate quantitative measurements of brachial artery cross-sectional vascular area and vascular volume elastic modulus using automated oscillometric measurements: comparison with brachial artery ultrasound. Hypertens Res 38:7 (2015), 478–484.
27. Yildirim, A., Kosger, P., Ozdemir, G., Sahin, F.M., Ucar, B., Kilic, Z., Carotid intima-media thickness and elastic properties of aortas in normotensive children of hypertensive parents. Hypertens Res 38:9 (2015), 621–626.
28. Boardman, H., Birse, K., Davis, E.F., Whitworth, P., Aggarwal, V., Lewandowski, A.J., et al. Comprehensive multi-modality assessment of regional and global arterial structure and function in adults born preterm. Hypertens Res 39:1 (2016), 39–45.
29. Daneshtalab, N., Smeda, J.S., Alterations in the modulation of cerebrovascular tone and blood flow by nitric oxide synthases in SHRsp with stroke. Cardiovasc Res 86:1 (2010), 160–168.
30. Kikkawa, Y., Kameda, K., Hirano, M., Sasaki, T., Hirano, K., Impaired feedback regulation of the receptor activity and the myofilament Ca2+ sensitivity contributes to increased vascular reactiveness after subarachnoid hemorrhage. J Cereb Blood Flow Metab 30:9 (2010), 1637–1650.
31. Harder, D.R., Kauser, K., Roman, R.J., Lombard, J.H., Mechanisms of pressure-induced myogenic activation of cerebral and renal arteries: role of the endothelium. J Hypertens Suppl 7:4 (1989), S11–S15 discussion S6.
32. Rubanyi, G.M., Endothelium-derived relaxing and contracting factors. J Cell Biochem 46:1 (1991), 27–36.
33. Litteri, G., Carnevale, D., D'Urso, A., Cifelli, G., Braghetta, P., Damato, A., et al. Vascular smooth muscle EMILIN-1 is a regulator of arteriolar myogenic response and blood pressure. Arterioscler Thromb Vasc Biol 32:9 (2012), 2178–2184.
34. Gray, A.M., Mason, A.J., Requirement for activin A and transforming growth factor–beta 1 pro-regions in homodimer assembly. Science 247:4948 (1990), 1328–1330.
35. Horiguchi, M., Ota, M., Rifkin, D.B., Matrix control of transforming growth factor-beta function. J Biochem 152:4 (2012), 321–329.
36. Munger, J.S., Sheppard, D., Cross talk among TGF-beta signaling pathways, integrins, and the extracellular matrix. Cold Spring Harb Perspect Biol, 3(11), 2011, a005017.
37. Annes, J.P., Munger, J.S., Rifkin, D.B., Making sense of latent TGFbeta activation. J Cell Sci 116:Pt 2 (2003), 217–224.
38. Yu, Q., Stamenkovic, I., Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14:2 (2000), 163–176.
39. Sato, Y., Rifkin, D.B., Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture. J Cell Biol 109:1 (1989), 309–315.
40. Mu, D., Cambier, S., Fjellbirkeland, L., Baron, J.L., Munger, J.S., Kawakatsu, H., et al. The integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1. J Cell Biol 157:3 (2002), 493–507.
41. Munger, J.S., Huang, X., Kawakatsu, H., Griffiths, M.J., Dalton, S.L., Wu, J., et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96:3 (1999), 319–328.
42. Schultz-Cherry, S., Murphy-Ullrich, J.E., Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism. J Cell Biol 122:4 (1993), 923–932.
43. ten Dijke, P., Arthur, H.M., Extracellular control of TGFbeta signalling in vascular development and disease. Nat Rev Mol Cell Biol 8:11 (2007), 857–869.
44. Raman, M., Cobb, M.H., TGF-beta regulation by EMILIN1: new links in the etiology of hypertension. Cell 124:5 (2006), 893–895.
45. Zacchigna, L., Vecchione, C., Notte, A., Cordenonsi, M., Dupont, S., Maretto, S., et al. EMILIN1 links TGF-beta maturation to blood pressure homeostasis. Cell 124:5 (2006), 929–942.
46. Ruiz-Ortega, M., Rodriguez-Vita, J., Sanchez-Lopez, E., Carvajal, G., Egido, J., TGF-beta signaling in vascular fibrosis. Cardiovasc Res 74:2 (2007), 196–206.
47. Lijnen, P.J., Petrov, V.V., Fagard, R.H., Association between transforming growth factor-beta and hypertension. Am J Hypertens 16:7 (2003), 604–611.
48. Aihara, K., Ikeda, Y., Yagi, S., Akaike, M., Matsumoto, T., Transforming growth factor-beta1 as a common target molecule for development of cardiovascular diseases, renal insufficiency and metabolic syndrome. Cardiol Res Pract, 2011, 2010, 175381.
49. Buday, A., Orsy, P., Godo, M., Mozes, M., Kokeny, G., Lacza, Z., et al. Elevated systemic TGF-beta impairs aortic vasomotor function through activation of NADPH oxidase-driven superoxide production and leads to hypertension, myocardial remodeling, and increased plaque formation in apoE(-/-) mice. Am J Physiol Heart Circ Physiol 299:2 (2010), H386–H395.
50. Roson, M.I., Cao, G., Della Penna, S., Gorzalczany, S., Pandolfo, M., Toblli, J.E., et al. Angiotensin II increases intrarenal transforming growth factor-beta1 in rats submitted to sodium overload independently of blood pressure. Hypertens Res 31:4 (2008), 707–715.
51. Ostriker, A., Horita, H.N., Poczobutt, J., Weiser-Evans, M.C., Nemenoff, R.A., Vascular smooth muscle cell-derived transforming growth factor-beta promotes maturation of activated, neointima lesion-like macrophages. Arterioscler Thromb Vasc Biol 34:4 (2014), 877–886.
52. Ketteler, M., Noble, N.A., Border, W.A., Transforming growth factor-beta and angiotensin II: the missing link from glomerular hyperfiltration to glomerulosclerosis?. Annu Rev Physiol 57 (1995), 279–295.
53. Liu, G.X., Li, Y.Q., Huang, X.R., Wei, L., Chen, H.Y., Shi, Y.J., et al. Disruption of SMAD7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-beta/SMAD3-NF.kappaB-dependent mechanisms in mice. PLoS One, 8(1), 2013, e53573.
54. Liu, Z., Huang, X.R., Lan, H.Y., SMAD3 mediates ANG II-induced hypertensive kidney disease in mice. Am J Physiol Renal Physiol 302:8 (2012), F986–F997.
55. Yang, F., Chung, A.C., Huang, X.R., Lan, H.Y., Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent SMAD pathways: the role of SMAD3. Hypertension 54:4 (2009), 877–884.
56. Kashiwagi, M., Shinozaki, M., Hirakata, H., Tamaki, K., Hirano, T., Tokumoto, M., et al. Locally activated renin-angiotensin system associated with TGF-beta1 as a major factor for renal injury induced by chronic inhibition of nitric oxide synthase in rats. J Am Soc Nephrol 11:4 (2000), 616–624.
57. Roson, M.I., Cavallero, S., Della Penna, S., Cao, G., Gorzalczany, S., Pandolfo, M., et al. Acute sodium overload produces renal tubulointerstitial inflammation in normal rats. Kidney Int 70:8 (2006), 1439–1446.
58. Juknevicius, I., Segal, Y., Kren, S., Lee, R., Hostetter, T.H., Effect of aldosterone on renal transforming growth factor-beta. Am J Physiol Renal Physiol 286:6 (2004), F1059–F1062.
59. Wang, D., Warner, G.M., Yin, P., Knudsen, B.E., Cheng, J., Butters, K.A., et al. Inhibition of p38 MAPK attenuates renal atrophy and fibrosis in a murine renal artery stenosis model. Am J Physiol Renal Physiol 304:7 (2013), F938–F947.
60. Shen, C., Lu, X., Li, Y., Zhao, Q., Liu, X., Hou, L., et al. EMILIN1 gene and essential hypertension: a two-stage association study in northern Han Chinese population. BMC Med Genet, 10, 2009, 118.
61. Shimodaira, M., Nakayama, T., Sato, N., Naganuma, T., Yamaguchi, M., Aoi, N., et al. Association study of the elastin microfibril interfacer 1 (EMILIN1) gene in essential hypertension. Am J Hypertens 23:5 (2010), 547–555.
62. Oh, V.M., Chua, B.M., Heng, C.K., Yeo, S.B., Yim, O.S., Yap, E.P., Association of intronic single-nucleotide polymorphisms in the EMILIN1 gene with essential hypertension in a Chinese population. J Hum Hypertens 26:9 (2012), 553–561.
63. Shimodaira, M., Nakayama, T., Potential roles of TGF-b1 and EMILIN1 in essential hypertension. Khullar, M., (eds.) Genetics and Pathophysiology of Essential Hypertension, 2012, InTech, Rijeka, Croatia.
64. Guo, D., Shen, C., Chen, Y., Yang, S., Wang, L., Jin, Y., et al. Polymorphisms of the TGFBRAP1 gene in relation to blood pressure variability and plasma TGF-beta1. Clin Exp Hypertens 37 (2015), 420–425.
65. He, F., Zhao, D., Deng, F., Zhong, H., Shi, X., Yang, J., et al. Association of TGF-beta1 gene polymorphisms in exon1 and blood levels with essential hypertension. Blood Press 19:4 (2010), 225–233.
66. Zhao, D., Hu, Q.H., Deng, F.M., Zhong, H., Guo, S.X., Shi, X.P., et al. [Association of the TGF-beta1 gene polymorphisms and blood TGF-beta 1 level with essential hypertension in Kazakh Chinese]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 27:4 (2010), 463–468.
67. Chen, J., Zhao, X., Wang, H., Chen, Y., Wang, W., Zhou, W., et al. Common variants in TGFBR2 and miR-518 genes are associated with hypertension in the Chinese population. Am J Hypertens 27:10 (2014), 1268–1276.
68. Raine, E.V., Reynard, L.N., van de Laar, I.M., Bertoli-Avella, A.M., Loughlin, J., Identification and analysis of a SMAD3 cis-acting eQTL operating in primary osteoarthritis and in the aneurysms and osteoarthritis syndrome. Osteoarthritis Cartilage 22:5 (2014), 698–705.
69. van de Laar, I.M., Oldenburg, R.A., Pals, G., Roos-Hesselink, J.W., de Graaf, B.M., Verhagen, J.M., et al. Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nat Genet 43:2 (2011), 121–126.
70. Bar-Klein, G., Cacheaux, L.P., Kamintsky, L., Prager, O., Weissberg, I., Schoknecht, K., et al. Losartan prevents acquired epilepsy via TGF-beta signaling suppression. Ann Neurol 75:6 (2014), 864–875.
71. Gol-Ara, M., Jadidi-Niaragh, F., Sadria, R., Azizi, G., Mirshafiey, A., The role of different subsets of regulatory T cells in immunopathogenesis of rheumatoid arthritis. Arthritis, 2012, 2012, 805875.
72. Gonzalo-Gil, E., Criado, G., Santiago, B., Dotor, J., Pablos, J.L., Galindo, M., Transforming growth factor (TGF)-beta signalling is increased in rheumatoid synovium but TGF-beta blockade does not modify experimental arthritis. Clin Exp Immunol 174:2 (2013), 245–255.
73. Jimeno, R., Leceta, J., Garin, M., Ortiz, A.M., Mellado, M., Rodriguez-Frade, J.M., et al. Th17 polarization of memory Th cells in early arthritis: the vasoactive intestinal peptide effect. J Leukoc Biol 98 (2015), 257–269.
74. Talaat, R.M., Mohamed, S.F., Bassyouni, I.H., Raouf, A.A., Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: correlation with disease activity. Cytokine 72:2 (2015), 146–153.
75. Yoon, B.R., Yoo, S.J., Choi, Y., Chung, Y.H., Kim, J., Yoo, I.S., et al. Functional phenotype of synovial monocytes modulating inflammatory T-cell responses in rheumatoid arthritis (RA). PLoS One, 9(10), 2014, e109775.
76. Smeda, J.S., Cerebral vascular changes associated with hemorrhagic stroke in hypertension. Can J Physiol Pharmacol 70:4 (1992), 552–564.
77. Paulson, O.B., Strandgaard, S., Edvinsson, L., Cerebral autoregulation. Cerebrovasc Brain Metab Rev 2:2 (1990), 161–192.
78. Strandgaard, S., Paulson, O.B., Cerebral blood flow in untreated and treated hypertension. Neth J Med 47:4 (1995), 180–184.
79. Busnadiego, O., Gorbenko Del Blanco, D., Gonzalez-Santamaria, J., Habashi, J.P., Calderon, J.F., Sandoval, P., et al. Elevated expression levels of lysyl oxidases protect against aortic aneurysm progression in Marfan syndrome. J Mol Cell Cardiol 85 (2015), 48–57.
80. Zhang, K., Pan, X., Zheng, J., Xu, D., Zhang, J., Sun, L., Comparative tissue proteomics analysis of thoracic aortic dissection with hypertension using the iTRAQ technique. Eur J Cardiothorac Surg 47:3 (2015), 431–438.
81. Barnett, C.P., Chitayat, D., Bradley, T.J., Wang, Y., Hinek, A., Dexamethasone normalizes aberrant elastic fiber production and collagen 1 secretion by Loeys-Dietz syndrome fibroblasts: a possible treatment?. Eur J Hum Genet 19:6 (2011), 624–633.
82. Nataatmadja, M., West, J., Prabowo, S., West, M., Angiotensin II receptor antagonism reduces transforming growth factor beta and SMAD signaling in thoracic aortic aneurysm. Ochsner J 13:1 (2013), 42–48.
83. Smeda, J.S., Daneshtalab, N., The effects of poststroke captopril and losartan treatment on cerebral blood flow autoregulation in SHRsp with hemorrhagic stroke. J Cereb Blood Flow Metab 31:2 (2011), 476–485.
84. Avina-Zubieta, J.A., Choi, H.K., Sadatsafavi, M., Etminan, M., Esdaile, J.M., Lacaille, D., Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 59:12 (2008), 1690–1697.
85. Baghdadi, L.R., Woodman, R.J., Shanahan, E.M., Mangoni, A.A., The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis. PLoS One, 10(2), 2015, e0117952.
86. Bergstrom, U., Jacobsson, L.T., Turesson, C., Cardiovascular morbidity and mortality remain similar in two cohorts of patients with long-standing rheumatoid arthritis seen in 1978 and 1995 in Malmo, Sweden. Rheumatology (Oxford) 48:12 (2009), 1600–1605.